This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Uniquest Pty Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Cleofe Calanasan: Innovator in Antimicrobial Therapeutics
Introduction
Cleofe Calanasan is a distinguished inventor based in Singapore, known for her contributions to the field of therapeutic compounds. She has made significant strides in developing innovative solutions to combat microbial infections, particularly through her research on lipopeptide compounds.
Latest Patents
Calanasan holds a patent for "Lipopeptide compounds and their use." This invention pertains to therapeutic compounds, specifically certain lipopeptide compounds that comprise a cyclic peptide bearing a lipid side chain. These compounds, collectively referred to as 'LP compounds,' exhibit antimicrobial properties, particularly antibacterial effects. The patent also covers pharmaceutical compositions that include these compounds and their applications in treating diseases mediated by microbes, especially bacterial infections.
Career Highlights
Throughout her career, Cleofe Calanasan has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to significantly impact the treatment of bacterial diseases, offering new avenues for therapeutic intervention.
Collaborations
Calanasan has collaborated with notable colleagues, including Rustum S Boyce and Joseph Cherian, to further her research and development efforts in the field of antimicrobial therapeutics.
Conclusion
Cleofe Calanasan's contributions to the field of therapeutic compounds highlight her role as a leading inventor in antimicrobial research. Her innovative work continues to pave the way for advancements in medical treatments.